Ing Investment Management »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Ing Investment Management

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Ing Investment Management from 13F filings

Historical chart of Ing Investment Management investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Ing Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Ing Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $131M 115M 1.14

More positions owned by Ing Investment Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Wisdomtree Tr Voya Yld Enhncd (UNIY)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Eli Lilly & Co. (LLY)
Servicenow (NOW)
JPMorgan Chase & Co. (JPM)
Wells Fargo Perp Pfd Cnv A (WFC.PL)
Palo Alto Networks (PANW)
Datadog Cl A Com (DDOG)

View all positions for Ing Investment Management

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Ing Investment Management
Highbridge Capital Management
Calamos Advisors
Tenor Capital Management
Davidson Kempner Capital Management
Advent Capital Management
Steelhead Partners
Lazard Asset Management
BlackRock
Magnetar Financial
State Street Corporation
OZ Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Lord, Abbett & Co
Bnp Paribas Arbitrage, Snc

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1